272 related articles for article (PubMed ID: 7357554)
1. Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma.
Lee C; Murphy GP; Chu TM
Cancer Res; 1980 Apr; 40(4):1245-8. PubMed ID: 7357554
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer.
Smolev JK; Heston WD; Scott WW; Coffey DS
Cancer Treat Rep; 1977; 61(2):273-87. PubMed ID: 872132
[TBL] [Abstract][Full Text] [Related]
3. Experience with an animal model for the study of prostatic carcinoma.
Lubaroff DM; Culp DA
Trans Am Assoc Genitourin Surg; 1977; 69():72-7. PubMed ID: 617916
[TBL] [Abstract][Full Text] [Related]
4. Models for development of nonreceptor methods for distinguishing androgen-sensitive and -insensitive prostatic tumors.
Isaacs JT; Isaacs WB; Coffey DS
Cancer Res; 1979 Jul; 39(7 Pt 1):2652-9. PubMed ID: 445468
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of a cloned cell line R3327H-G8-A1 derived from the dunning R3327H rat adenocarcinoma.
Sestili MA; Norris JS; Smith RG
Cancer Res; 1983 May; 43(5):2167-75. PubMed ID: 6299542
[TBL] [Abstract][Full Text] [Related]
6. Isolation and biochemical characteristics of a molecular form of epididymal acid phosphatase of boar seminal plasma.
Wysocki P; Strzezek J
Theriogenology; 2006 Dec; 66(9):2152-9. PubMed ID: 16919323
[TBL] [Abstract][Full Text] [Related]
7. Human prostatic acid phosphatases: purification of a minor enzyme and comparisons of the enzymes.
Vihko P
Invest Urol; 1979 Mar; 16(5):349-52. PubMed ID: 429130
[TBL] [Abstract][Full Text] [Related]
8. [Purification of prostatic acid phosphatase and prostate specific antigen from human seminal plasma].
Aoki T; Tanaka T; Kataoka S; Horikawa H; Watabe H
Hokkaido Igaku Zasshi; 1988 Nov; 63(6):963-70. PubMed ID: 2470661
[TBL] [Abstract][Full Text] [Related]
9. Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
Broghamer WL; Richardson ME; Faurest S; Parker JE
Acta Cytol; 1985; 29(3):274-8. PubMed ID: 3890441
[TBL] [Abstract][Full Text] [Related]
10. Characterization of anti-prostatic acid phosphatase monoclonal antibody and its medical significance.
Kuciel R; Mazurkiewicz A; Ostrowski WS; Stachura J; Steuden I; Szkudlarek J; Radzikowski C
Biotechnol Appl Biochem; 1988 Jun; 10(3):257-72. PubMed ID: 3395468
[TBL] [Abstract][Full Text] [Related]
11. Immunofluorescent localization of an androgen-dependent isoenzyme of prostatic acid phosphatase in rat ventral prostate.
Terracio L; Rule A; Salvato J; Douglas WH
Anat Rec; 1985 Oct; 213(2):131-9. PubMed ID: 3907418
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma.
Presnell SC; Borchert KM; Glover WJ; Gregory CW; Mohler JL; Smith GJ
Carcinogenesis; 1998 Apr; 19(4):585-90. PubMed ID: 9600341
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of radioimmunoassay of human prostate-specific acid phosphatase in the diagnosis and follow-up of therapy in prostatic carcinoma.
Vihko P; Lukkarinen O; Kontturi M; Vihko R
Cancer Res; 1981 Mar; 41(3):1180-3. PubMed ID: 7459859
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein exhibiting immunological and enzymatic activities of human prostatic acid phosphatase.
Lin MF; Lee CL; Sharief FS; Li SS; Chu TM
Cancer Res; 1983 Aug; 43(8):3841-6. PubMed ID: 6861148
[TBL] [Abstract][Full Text] [Related]
15. In vitro propagation of prostate adenocarcinoma cells from rats.
Chang CF; Pollard M
Invest Urol; 1977 Mar; 14(5):331-4. PubMed ID: 557462
[TBL] [Abstract][Full Text] [Related]
16. There are multiple forms of glyceraldehyde-3-phosphate dehydrogenase in prostate cancer cells and normal prostate tissue.
Epner DE; Coffey DS
Prostate; 1996 Jun; 28(6):372-8. PubMed ID: 8650074
[TBL] [Abstract][Full Text] [Related]
17. Isozymes of acid phosphatase in normal and cancerous human prostatic tissue.
Foti AG; Herschman H; Cooper JF
Cancer Res; 1977 Nov; 37(11):4120-4. PubMed ID: 908045
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation.
Chu TM; Wang MC; Scott WW; Gibbons RP; Johnson DE; Schmidt JD; Loening SA; Prout GR; Murphy GP
Invest Urol; 1978 Jan; 15(4):319-23. PubMed ID: 75196
[TBL] [Abstract][Full Text] [Related]
19. Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor.
Lokeshwar BL; Hurkadli KS; Sheth AR; Block NL
Cancer Res; 1993 Oct; 53(20):4855-9. PubMed ID: 8402673
[TBL] [Abstract][Full Text] [Related]
20. Identification of cultured, human, malignant, prostatic epithelial cells.
Stonington OG; Szwec N; Webber M
Natl Cancer Inst Monogr; 1978 Dec; (49):31-3. PubMed ID: 372822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
